N/A N=118 Weight Management for Improved Pregnancy Outcomes
Obesity · Pregnancy
Primary: Maternal Weight Change — 1.2; -2.6 kg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=16 Acute Exercise Effects in Obese Pregnancy
Pregnancy Complications · Obesity · Pre-Eclampsia
Primary: Oral Glucose Insulin Sensitivity (OGIS) Index — 405.0; 426.0; 418.9 uU/mL
N/A N=360 Lifestyle and Pregnancy: The Clinical Effect of Lifestyle Intervention During Pregnancy in Obese Women
Maternal Obesity · Gestational Weight Gain · Obstetric Complications
Primary: Cesarean Section
Phase 4 N=20 A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity
Pregnant Patients With Obesity
Primary: Number of Participants Delivered by Cesarean — 3; 3 Participants
Phase 4 N=236 Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial
Obesity · Labor Induction · Cesarean Delivery
Primary: Number of Participants With a Need for Cesarean Delivery — 51; 53 Participants
N/A N=40 Effects of Obesity and Physical Inactivity on Pregnancy Outcomes
Obesity · Sedentary
Primary: Neonatal Adiposity — 11.2; 12.4 % fat
Early Phase 1 N=186 Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term
Obesity · Induction of Labor Affected Fetus / Newborn
Primary: Number of Participants With Cesarean Delivery — 27; 37 Participants
Phase 3 N=44 17OHP-C Dosing Among Obese Pregnant Women
Premature Birth · Absorption; Chemicals
Primary: Change in Mean Trough Levels of 17-OHPC in the Three Groups at 20-22 Weeks, 27-29 Weeks and 34-36 Weeks. — 10.1; 13.0; 18.0; 11.5 ng/ml
N/A N=281 Maternal-Offspring Metabolics:Family Intervention Trial
Pregnancy · Weight Gain
Primary: Gestational Weight Gain (GWG) — 12; 10 kg — p=0.01
Phase 1 N=22 PED NEONAT 20-000599 Fetal Body Composition
IUGR · Gestational Diabetes · Pregnancy Related
Primary: Maternal Visceral Adipose Tissue Volume — 97593; 169626; 96787 mm3
N/A N=82 Physical Exercise Influence Among Overweight and Obese Pregnant Women
Obesity · Overweight
Primary: Gestational Weight Gain — 10.3; 11.5 kg — p=<0.05
N/A N=72 Determinants of Gestational Weight Gain in Obese Pregnant Women
Energy Intake · Energy Expenditure
Primary: Energy Intake — 2908; 2698; 2581 kilocalories per day
N/A N=264 Preventing Excessive Gestational Weight Gain in Obese Women
Obesity
Primary: Weight Gain Per Week of Observation — 0.39; 0.33 kg/wk
N/A N=148 Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women
Diabetes
Primary: Gestational Weight Gain — 7.9; 10.4 kg
N/A N=31 Healthy Mom Zone: A Gestational Weight Gain Management Intervention
Overweight and Obesity · Physical Activity · Weight Change, Body
Primary: Gestational Weight Change — 6.9; 8.8 kilograms
N/A N=416 Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy
Obesity · Overweight · Pregnancy Related
Primary: Percentage of Women With Excessive Gestational Weight Gain — 126; 119 Participants
Phase 4 N=178 Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
Hypotension
Primary: Incidence of Nausea and Vomiting — 59; 37 participants
N/A N=135 Starting Pediatric Obesity Prevention in Pregnancy
Obesity · Pregnancy
Primary: Gestational Weight Gain — 0; 0; 0; 0 Participants
Phase 3 N=220 Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida
Pre-Eclampsia · Hypertension in Pregnancy · Obesity
Primary: Number of Participants With Preeclampsia Diagnosis With Severe Features Based on Clinician Diagnosis — 37; 41 Participants
N/A N=962 Early Gestational Diabetes Screening in the Gravid Obese Woman
Gestational Diabetes · Obesity
Primary: Number of Participants With a Composite Perinatal Outcome — 235; 261 Participants
N/A N=95 Early Screening and Treatment of Women With Prediabetes in Pregnancy
Diabetes · Pregnancy
Primary: Number of Patients With a Diagnosis of Gestational Diabetes at 26 Weeks Gestation. — 19; 23 Participants — p=0.32
N/A N=108 Obstructive Sleep Apnea in Pregnancy
Sleep Apnea, Obstructive · Pregnancy · Obesity, Morbid
Primary: Number of Participants With a Negative Obstructive Sleep Apnea (OSA) Home Sleep Test Result — 61 Participants
N/A N=30 The MOTHER (Mobile Technologies to Help Enhancing Regular Physical Activity) Trial for Pregnant Women
Physical Activity
Primary: Physical Activity Monitor Measured Steps — 1166.6; 1062.6; 1092.1; 804.3 step
N/A N=70 Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women
Obesity · Weight Gain, Maternal
Primary: Percent Change in Body Weight — 10.9; 9.6 percentage change
N/A N=54 Personalized Management of Body Weight During Pregnancy
Weight Gain During Pregnancy
Primary: Count of Women Who Have Excess Gestational Weight Gain — 10; 11; 11 Participants
Phase 4 N=64 Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
Obesity · Contraception
Primary: Number of Participants With Delay in Follicular Rupture Beyond 5 Days — 46; 43; 12 Participants
N/A N=1,335 A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women
Gestational Weight Gain
Primary: Total Gestational Weight Gain (GWG) — 10.5; 11.3 kilograms — p=0.014
N/A N=312 Optimizing Health From Pregnancy Through One Year Postpartum
Obesity · Pregnancy Related
Primary: Maternal Weight — 196.59; 201.03; 193.70; 201.66 pounds — p=.80
Phase 4 N=30 Increased Cefazolin During Cesarean Delivery in Obese Population
Obesity · Obesity, Morbid · Pregnancy
Primary: Achievement of Minimal Inhibitory Concentrations Within Adipose and Serum Sampled at Time of Cesarean Delivery — 22.4; 9.6 mg/g
Phase 4 N=66 Magnesium Sulfate in Obese Preeclamptics
Preeclampsia
Primary: Maternal Serum Magnesium Level at 4 Hours After Administration — 3.53; 4.41 mg/dL